Cancer and its treatments introduce various adverse effects that may affect survivors' physical, cognitive and psychological functioning. Frequently both tolerance to activity and exercise are affected as well. Rehabilitation providers should have substantive knowledge about the effect of cancer progression and common side effects associated with antineoplastic treatment to safely integrate rehabilitation interventions. Rehabilitation may mitigate loss of function and disability; however, these patients are among the most medically complex that providers treat. This report provides a focused review that synthesizes the current evidence regarding disease progression and oncology-directed treatment side effects within the context of safety considerations for rehabilitation interventions throughout the continuum of cancer care. Descriptive information regarding the evidence for precautions and contraindications is provided so that rehabilitation providers can promote a safe plan of rehabilitation care. It is incumbent upon but also challenging for rehabilitation providers to stay up to date on the many advances in cancer treatment, and there are many gaps in the literature regarding safety issues. Although further research is needed to inform care, this review provides clinicians with a framework to assess patients with the goal of safely initiating rehabilitation interventions.
Introduction
Cancer-and oncology-directed treatments introduce a variety of side effects that can adversely affect multiple body systems during and after disease treatment [1] . Each disease treatment modality (eg, surgery, chemotherapy, radiation) may individually or collectively introduce risk for a host of potential safety issues. In addition, a complex array of biopsychosocial factors such as an individual's pre-existing comorbidities, polypharmacy, and other lifestyle factors also affect and amplify risk for adverse side effects during treatment.
It is incumbent upon rehabilitation providers to be knowledgeable about safety issues related to the disease or progression of the cancer as well as side effects and serious adverse events associated with antineoplastic therapies that may have an impact on care. Early identification and management of emerging adverse events may affect morbidity and survival [2] . The purpose of this report is to provide a focused narrative review of the current literature regarding safety with rehabilitation interventions for individuals with cancer with consideration for the disease process, side effects of disease treatment, and associated precautions and contraindications.
Pretreatment Risk Assessment
Pretreatment risk assessment helps to identify potential safety problems and to establish a patient's baseline physical and functional status. Understanding the disease and treatment trajectory provides an opportunity to assess the potential risk for problems that may affect rehabilitation interventions. Before initiating antineoplastic therapies, an extensive medical workup is undertaken to diagnose, stage, and determine a treatment plan for the disease. Baseline imaging, laboratory, and other testing provides insight into various markers and system functions. In addition to a comprehensive medical history to identify existing comorbidities and medication regimens, assessing functional measures is important in predicting mortality and disease-free survival and prognosticating functional decline. An ideal construct for rehabilitation professionals is to obtain a comprehensive functional assessment before the initiation of any cancer-directed intervention, as this may optimize performance outcomes during and after treatment [3] and will help identify early functional status decline [4] .
Various models of pretreatment assessment and planning have been investigated and typically involve an interdisciplinary team-based approach. These include the prospective surveillance model, multimodal prehabilitation, and enhanced perioperative surgical recovery programs [5] .
Safety Considerations With Antineoplastic Treatment Adverse Effects
During active oncology-directed treatment, various modalities are sequentially and sometimes concurrently delivered. Rehabilitation providers must be aware of postsurgical precautions and contraindications regarding movement and activity restrictions so that a plan of care can be developed that facilitates tissue healing, prevents restrictions in function, and optimizes functional status. These precautions, however, should be balanced with evidence-based mobilization and postoperative activity recommendations, and should be informed by surgical precautions and guidance. Mobility and exercise participation in the acute postoperative stage of treatment may reduce the risk of adverse events [6, 7] , affect overall length of stay [8] , and reduce readmissions and complications in various cancer populations [6, 9] .
Chemotherapeutic interventions typically include multidrug therapies administered cyclically over a standardized period of time. Chemotherapy side effects contribute to multisystem dysfunction and have considerable influence on the safe administration of a rehabilitation plan of care. Table 1 identifies common chemotherapy, immunotherapy, and hormonal drugs and side effects (www.cancer.gov) that may be particularly relevant to rehabilitation specialists.
Hematological Compromise
Myelosuppression is a common side effect associated with nearly all chemotherapy and immunosuppressive agents, particularly corticosteroids, and thus presents significant implications for rehabilitation interventions. Hematologic compromise can result in cytopenias that increase risk of infection, compromise metabolic function, and alter physiological responses to exercise in severe circumstances. Table 2 provides an overview of laboratory values and safety thresholds for consideration by the rehabilitation provider.
The cancer population, as a cohort, has a higher rate of transfer to acute care hospital during inpatient rehabilitation, and it is important to identify the risk factors for transfer [10] . In a study by Guo et al of 98 individuals with cancer undergoing inpatient rehabilitation, hemoglobin levels and absolute neutrophil and platelet counts at the time of admission were not associated with acute care transfers [11] . In another study by Fu et al, 143 lymphoma patients undergoing inpatient rehabilitation, male gender, creatinine >1.3, and hematopoietic stem cell transplantation were associated with a higher rate of transfer to acute service hospitals [12] .
Anemia is a frequent complication of cancer and cancer treatment including chemotherapy and radiation [13] . Worsening anemia reduces exercise tolerance and endurance, leading to symptoms of fatigue, dizziness, and hemodynamic instability [14] . Although aerobic capacity is improved with higher hemoglobin levels, it is unclear whether there is a level of hemoglobin below which functional outcomes are compromised [14] . Caution should be used in prescribing progressive resistive and moderate-to high-intensity aerobic exercise in individuals with severe anemia (hemoglobin 8 g/dL) [15, 16] . Low-intensity exercise may be beneficial to promoting improvements in blood counts. Rehabilitation professionals should monitor hemodynamic, functional, and exertional status as well as patient symptoms such as chest pain, lightheadedness, and inappropriate dyspnea [17] .
Thrombocytopenia occurs with myelosuppression therapies and affects red blood cell counts. Individuals with platelet counts of <10,000 cells/mL are at significant risk for spontaneous hemorrhage and, as per current guidelines, will receive prophylactic transfusions [18] . Those with counts of <20,000 cells/mL are at increased risk, and special consideration for rehabilitation intervention should be considered; generally, activity is restricted to walking and activities of daily living [19] . Individuals with counts of >20,000 cells/mL can complete light exercise with close symptom monitoring. In general, this includes maintaining blood pressures below 170/100 mm Hg and screening the patient for symptoms of bleeding, including bruising and bleeding around the gums [20] . Those with counts of >30,000 cells/mL can engage in moderate exercise and light resistive exercise within tolerance [19] .
Chemotherapy-induced neutropenia (absolute neutrophil count <500 mm 3 /L) typically occurs 3-7 days after administration of chemotherapy. Neutropenia predisposes patients to infection. Typical signs and symptoms of infection are often absent in neutropenia, and fever remains the earliest sign of occult infection. Primary sites of infection are the gastrointestinal tract, sinuses, lungs, and skin [21] . Clinicians should practice hand hygiene with antimicrobial products during every patient encounter. The use of barrier precautions such as gowns, gloves, and masks are usually unnecessary, as patients are more likely to get infected with their own flora [22] . The Centers for Disease Control guidelines advise against barrier protection except when "the risk of infection from healthcare providers is excessive" [23] . There is no compelling evidence that rehabilitation interventions are contraindicated due to neutropenia, but special consideration should be given to individuals experiencing side effects such as fatigue, malaise, dizziness, or lethargy, and rehabilitation therapy should be self-limited based on patient preferences [16] .
Further consideration is warranted to prevent infection by reducing exposure to potential pathogens such as those found in public therapy spaces [24] . Neutropenic infections are a major cause of morbidity and mortality in individuals undergoing cancer treatment [21] . Common infections include sepsis, cellulitis, pneumonia, urinary tract infections and colitis [25, 26] . Rehabilitation providers should closely monitor at-risk patients for early signs and symptoms of infection so that medical management can be expedited when needed [27] .
Hematological considerations are particularly important in patients undergoing bone marrow transplantation. Pretransplantation induction treatment involves high-dose chemotherapy, frequently with concurrent irradiation. Bone marrow transplantation is typically undertaken after traditional antineoplastic therapies have failed to put an individual into remission. These patients are cytopenic at the time of transplantation and remain so for weeks afterward. There is additional concern, as these individuals have a history of antineoplastic therapies that can result in other adverse effects such as neurotoxicities affecting peripheral nerve function, myopathy due to chronic corticosteroid use, prolonged immobility, nutrition deficits, and cognitive dysfunction [28] . Given the substantial need for rehabilitation services in this population, it is imperative to provide safe rehabilitation interventions. Dimeo et al suggest that exercise not only mediates better physical performance at discharge in this population, but a shorter duration of anemia, neutropenia, thrombocytopenia, and length of hospitalization [29] . 
Table 2
General rehabilitation considerations in the context of hematological compromise [13, 16, 19] Blood Count Rehabilitation Considerations
White blood cells >11.0 10 9 /L: Symptom-based approach, monitor for fever <4.0 10 9 /L: Symptom-based approach, monitor for fever <1.5 10 9 /L (Neutropenia): Symptom-based approach, neutropenic precautions based on facility guidelines Mild <1.5 10 9 /L Moderate 0.5-1.0 10 9 /L Severe <0.5 10 9 /L Platelets <150,000 cells/mL (Thrombocytopenia): Symptom-based approach, monitor tolerance to activity >50,000 cells/mL: Progressive exercise as tolerated, aerobic, and resistive with monitoring for symptoms associated with bleeding >30,000 cells/mL: Active range-of-motion exercises, moderate exercise, aquatic therapy based on immune status >20,000 cells/mL: Light exercise, walking, activities of daily living without strenuous effort; assess fall risk and implement safety plan for falls prevention <20,000 cells/mL: Understand transfusion status or plan of care, walking, light activities of daily living, symptom monitoring, precaution for falls Hemoglobin Reference values Male: 14-17.4 g/dL Female: 12-16 g/dL <11 g/dL (anemia): Establish baseline vital signs; may be tachycardic or present with orthostatic hypertension; symptom-based approach to intervention, monitoring self-perceived exertion <8 g/dL (severe anemia): Close monitoring of symptoms and vital signs with intervention; transfusion may or may not be indicated based on individual presentation; short periods of intervention, symptom-limited; education for energy conservation S418
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Cardiopulmonary Toxicity
Malignant tumors are more likely to involve the lungs than the heartdeither as primary or metastatic disease. In advanced cancer, there may be significant compromise of pulmonary function due to metastatic disease. Individuals with advanced cancer may have cachexia with severe muscle wasting that may affect cardiac function as well ("cardiac cachexia"). Antineoplastic therapies such as chemotherapy and immunotherapy drugs, as well as radiation therapy to the chest wall, can affect cardiac and pulmonary function, both during and after cancer-directed treatments [30] . One of the most commonly used chemotherapy drug classes, anthracyclines, may have a significant and irreversible impact on cardiac function, primarily resulting in reduced left ventricular function. Over time, this reduces overall ejection fraction and compromises long-term cardiac function. Trastuzumab is a targeted drug that is frequently used in breast and other cancers and has well-known potential for cardiac toxicity. The implications manifest in symptoms of systemic edema, shortness of breath, dyspnea, and lung congestion in severe cases. Bleomycin and methotrexate are agents that commonly lead to pulmonary compromise, including pulmonary inflammation and fibrosis.
Exposure of the chest wall to radiation has the potential to adversely affect both cardiac and pulmonary function and may be progressive over time. Individuals receiving >30-35 Gy exposure to the chest wall are at risk for radiation-associated heart damage [30] . These dose levels are typically eclipsed with standard breast, lung, and various Hodgkin treatments, elevating the risk in these populations. Radiation-related changes include structural damage to the myocardium, coronary arteries, valves, and the conduction system. These complications often lead to diastolic dysfunction and blood flow abnormalities. Cardiac changes typically manifest clinically at least 6 to 12 months after radiation, necessitating awareness and monitoring for symptoms of cardiovascular and pulmonary dysfunction. The impact on cardiac function, however, can be identified even 20 years after the completion of radiation therapy, affecting long-term morbidity and function [31] .
Vital sign monitoring throughout the duration of cancer-directed treatments is recommended. A baseline echocardiogram is usually obtained in individuals undergoing cardiotoxic chemotherapeutic regimens and may be repeated at various stages of treatment or after treatment. Low-intensity exercise, administered during chemotherapy cycles, may be protective against anthracycline-induced cardiotoxicity [32] , but recommendations regarding timing, frequency, intensity, and mode of exercise are lacking [33] . When prescribing exercise interventions for this population, risk factors such as dose scheduling, prior cardiac comorbidities, and baseline vital signs should be considered. Edema monitoring is necessary to observe and to differentially diagnose cardiopulmonary edema symptoms from the onset of lymphedema.
Late effects of cardiovascular compromise are especially prominent and warrant consideration in adult survivors of childhood and adolescent cancers. The deleterious impact on cardiac function is prevalent; nearly 50% demonstrate cardiac-related comorbidity that compromises function 20-30 years after completion of treatment [34] .
Rehabilitation providers seeking to implement a plan of care should be aware of the risk for reduced tolerance to exercise, altered baseline vital signs, and altered physiological responses to rehabilitation interventions. Monitoring during rehabilitative interventions should include a focus on patient self-report of tolerance to exercise via the Borg Scale or another index. Observation for symptoms that may herald undetected cardiac dysfunction or exercise that is too vigorous for someone with known heart disease, include excessive fatigue, sweating, or pallor changes with exercise or activity, and severe shortness of breath.
Neurotoxicity
Chemotherapy-induced peripheral neuropathy is a well-known complication with taxane-based as well as platinum-based chemotherapeutic agents. Acute presentation of neuropathies includes sensory manifestation in the distal extremities. The neuropathic changes are typically progressive with additive chemotherapy cycles. The progression of sensory changes presents in a stocking/glove pattern. In more severe cases, motor disturbance is noted, primarily in the lower extremities.
Although neuropathies occur during chemotherapy cycles, the symptoms tend to abate after the completion of treatment. However, persistent impact on sensation and proprioception are notable and are shown to have a negative impact on balance, gait, and mobility even >5 years after the completion of treatment [35] . Individuals who receive neurotoxic doublets are at greater risk for persistent neuropathic impairment. Of importance is the evidence elucidating the significantly increased risk of falls in the population of individuals treated with neurotoxic chemotherapy agents. Fall risk is 2-3 times greater in the population of individuals with a history of receiving neurotoxic chemotherapeutic agents [36] .
There are significant rehabilitation implications for the population of individuals treated with neurotoxic chemotherapeutic agents. Ideally, a baseline assessment of sensation, strength, and balance is completed before initiating chemotherapy. Continued screening for balance change over time, observation of gait deviation, and triage for rehabilitation intervention to manage emerging impairments is recommended [37] . Severe neuropathy with motor changes may affect safety and may necessitate intervention to mitigate balance deficits and to enhance gait and stability [38] . A comprehensive falls prevention program is an effective strategy that should be proactively implemented to improve functioning [39, 40] . Providing assistive devices and/or orthoses may be required to maintain patient safety.
Lymphedema
The natural history of lymphedema is typically a slow, progressive swelling that appears asymmetrically in the limbs after lymphadenectomy or radiation therapy. New-onset lymphedema is an important safety concern primarily because of the risk of deep vein thrombosis, cancer recurrence, or infection [41] .
Several studies have examined the safety of exercise in regard to the development and exacerbation of lymphedema and have found that, under controlled circumstances, exercise does not exacerbate this condition or have a significant impact on worsening symptoms [42] [43] [44] . There is no strong evidence basis for the use of compression garments during exercise for prophylactic purposes; however, early use of compression therapy in the presence of early, subclinical lymphedema is safe and effective [45] . Individuals with lymphedema should be advised to exercise with some form of compression on their limbs to prevent fluid accumulation. Any signs of redness, erythema, pain, or new onset or exacerbation of swelling should be referred for more extensive medical management. Cellulitis infections are common in individuals with lymphedema and require antibiotic therapy before continuation of rehabilitation interventions.
For individuals in whom lymph nodes have been resected as a standard part of cancer surgery, astute observation of any changes in the limb that indicate an emerging infection should be addressed. An individualized rehabilitation treatment plan should be developed for this at-risk population with precautions to avoid unnecessary strain and injury to the limb that may cause the onset of lymphedema [45] .
Frailty
Frailty is a clinical syndrome that may be found in individuals >65 years of age and that is characterized by a loss of physiologic reserve secondary to reduced physiological capacity, weight loss, weakness, slow walking speed, self-reported exhaustion, and low physical activity [46, 47] . Because cancer occurs disproportionately among people >70 years of age, many cancer survivors have frailty symptoms compounded by the negative effects of cancer-directed treatments [48] . Frailty is associated with falls, hospitalizations and increased mortality [49] . A recent study analyzing more than 12,000 patients 65 years of age found that the prevalence of falls was significantly higher after cancer treatment than before treatment among individuals with prostate and lung cancer, and the prevalence of balance/walking problems were significantly higher after diagnosis in non-Hodgkin lymphoma and breast, prostate, and lung cancer [50] . Frail patients, specifically, pose a challenge to rehabilitation physicians who work with cancer survivors. Frailty has been associated with poorer rehabilitation outcomes and functional gains.
The Comprehensive Geriatric Assessment (CGA) has received attention as a comprehensive battery of tests that assess various domains of functioning and can be used to stratify patients into high-versus low-risk categories to predict their tolerance to cancer therapies and risk for side effects of chemotherapy [51] . The CGA may be a more comprehensive and sensitive indicator to identify functional decline than the current performance status measures used in oncology practice [52] . Interventions such as optimizing nutrition and muscle mass may delay frailty and are safe in the geriatric population [9] . In a review of studies on exercise interventions in frail institutionalized adults, balance and functional training were shown to be effective in improving functional performance, activities of daily living, and quality of life [53] .
Osseous Fragility
Osteoporosis and secondary bone loss affect bone health in cancer survivors, most commonly in hormonally driven breast and prostate cancer [54, 55] . Osteoporosis worsens with prolonged exposure to hormonal therapies, increasing fracture risk with increased duration of treatment [56, 57] . Rehabilitation providers should identify meaningful changes over time that may suggest increased risk and should modify rehabilitative interventions to optimize safety. Weight-bearing exercise may have a protective effect in mitigating bone density depletion during hormonal therapy interventions [58] .
Bone metastases occur prevalently in the most commonly occurring cancers; breast, lung, and prostate [59, 60] . Bone lesions often result in pain, spinal cord compression, fracture, and hypercalcemia reducing quality of life and limiting functional mobility [61, 62] . Although rehabilitative weight-bearing activities can have a positive impact on bone density, mobilizing individuals with bone lesions is challenging due to pain and fracture risk during therapeutic exercise [63] .
Metastatic lesions of the long bones and spine present the greatest risk of pathologic fractures, making fracture risk assessment of great importance to rehabilitation providers [60] . A scoring system developed by Mirels et al [64] assigns a severity score to each of 4 factors associated with fracture: namely, site, size, type of lesion, and type of pain reported (Table 3) . This system enables an aggregate score that supports fracture risk stratification so that appropriate mobility interventions may be initiated.
According to the recommendation of Mirels et al, prophylactic fixation is indicated for a lesion with a score of 9. A lesion with a score of 7 can be managed using radiotherapy and drugs. A score of 8 presents a clinical dilemma and requires clinical judgment of the criteria. Functional pain has been identified as the single best predictor of pathological fracture [64] .
Another stratification system by Harrington suggests that lytic and blastic lesions in long bones can develop pathologic fractures when >50% of the cortex is destroyed, and lesions of the proximal femur are more likely to fracture if they are >2.5 cm or if they are associated with avulsion of the lesser trochanter. Such lesions should be referred for prophylactic fixation [65] .
Rehabilitation is indicated in the presence of bone metastases to maintain function and promote safety and fracture prevention with activities of daily living [66] . Of importance are fall prevention strategies and education for safety with activities that require lifting and carrying heavy objects. A comprehensive mobility assessment is necessary, as the sheer number of bone lesions and location of metastatic sites may not be associated with functional mobility loss in the short term [67] . Rehabilitation interventions are generally safe and effective and do not increase the risk for fractures [66, [68] [69] [70] . General safety measures are outlined in Table 4 and target restricting excessive resistive, compressive, or rotational torque-like forces on an involved limb or region [71] . Individuals with more severe fracture risk may benefit from offloading the affected limb and using assistive devices or orthoses to safely enhance function and mobility. Caregiver education should be emphasized in the rehabilitation care plan to optimize safety and function in the home environment.
Advanced Cancers
Functional impairments are prevalent in patients with advanced cancer and can lead to disability, increased caretaker dependency, and psychological distress [72] . Safety considerations should be broadened, and rehabilitation assessment should extend beyond the primary functional limitation, as the multisystem impact of advanced cancer jeopardizes safe functioning [73] . Patients with advanced cancer often have a range of comorbid conditions, polypharmacy considerations, and impact functioning, and require a more complex rehabilitative prescription [72, 74] .
Cachexia is a common condition related to advanced cancer. Symptoms include marked weight loss, loss of lean muscle and muscle atrophy, fatigue, weakness, and loss of appetite, which negatively impact function. Sarcopenia is a condition of lean muscle loss and muscle atrophy. Sarcopenia may also be seen in advanced cancer populations but is a different condition from cachexia; although sarcopenia may be a component of cachexia, not all individuals with sarcopenia are cachectic [75] . Sarcopenia can be identified by low muscle mass and reduced gait speed. This differentiation is important, as exercise, in the absence of appropriate protein and energy balance, may pose a risk for further functional decline in the cachectic population [76] . Rehabilitation interventions should be undertaken with insight and input from an interdisciplinary team that include an understanding of nutritional support and inflammatory profiles of the patient balanced with physical activity and muscle training interventions [77] .
Central and peripheral neural structures may be affected by a primary or metastatic tumor as well as oncology-directed treatment (eg, chemotherapy). Neurological changes may be the first presenting sign of metastatic disease and warrant close follow-up and triage for medical management. Neurological symptoms are often consistent with the spinal level or central location of the lesion. Patients may present with cognitive changes, memory loss, affective and personality changes, altered mental status, speech and word finding complications, as well as sensory or motor dysfunction including radiculopathy or myelopathy [78] . Autonomic dysfunction may also occur related to chemotherapy or other antineoplastic treatment issues. Rehabilitation providers should monitor for any neurological status changes during and after intervention, and should monitor pain and vital sign changes during intervention. Caregiver education is also important, as patients may have altered safety judgement, reduced reflexive reactions, poor visual acuity, and word-finding issues that make it difficult to function independently. Assessment for home modifications and adaptive equipment evaluations should be considered to help reduce the risk of falling and to improve overall safety in the home. Education for compensatory strategies using assistive devices, orthotics, and wheelchairs can improve the safety of individuals while promoting optimal functioning. Partnering with palliative care services to develop patient-centered protocols that span the oncologic spectrum can combine rehabilitation interventions with the treatment of cancer-related pain, anxiety, and psychosocial and spiritual needs [79] .
Safety Considerations With Rehabilitation Interventions
Exercise
Exercise has been extensively studied across the cancer care continuum, including interventions before treatment [6, 80, 81] , during active treatment [82, 83] , and after the completion of treatment [82, 84] . Timing and type of exercise affects various biological and physiological markers, psychosocial factors, and functional impairments differently [82, 85] . Overall, tolerance to treatment and functional outcomes in a variety of cancer types are improved when exercise is initiated before or during cancer treatment [6, 44, 81] . Unique considerations are necessary based on the type of cancer and the body structures affected by cancer-directed therapies.
Exercise training and maximal and submaximal exercise testing in persons with breast cancer is relatively safe [42, 43, [86] [87] [88] . However, because 35%-58% of breast cancer survivors report persistent shoulder and arm pain [89] , it is important to minimize the risk of musculoskeletal injuries that may result from surgical intervention or other therapies. Because women with breast cancer commonly receive cardiotoxic chemotherapeutic agents, awareness of cardiac compromise is warranted. Ideally, a tailored exercise program is developed and initially supervised by a rehabilitation provider [90] .
Exercise interventions are generally safe during and after prostate cancer treatment [69, 91] . More than 50% of individuals undergoing prostate cancer treatment will receive androgen deprivation therapy (ADT) to alter hormonal impact on tumor growth. ADT is associated with muscle mass depletion and bone density loss, which directly affect safety with rehabilitation interventions. Aerobic and resistive exercise interventions lessen the impact of ADT and promote restoration of muscle mass and mitigate bone density loss [92] . Numerous prehabilitation and rehabilitation trials have identified positive benefits of exercise as well as its safety and feasibility in the lung cancer population [93] . Exercise is generally well tolerated and beneficial in controlled clinical settings, and evidence supports moderate-intensity exercise for this population [6, 94, 95] . Vital signs, oximetry, and respiration should be closely monitored during exercise, and individual interventions and testing should be self-limited by the patient [74] .
Evidence supports exercise as a safe intervention in women during and after gynecological cancer treatment [96, 97] . Lymphedema of the lower extremities may be associated with gynecological cancer and its treatment, warranting consideration of lower-extremity monitoring for individuals who have had inguinal lymph node dissection and/or radiation therapy [41] .
Exercise interventions such as walking, stationary cycling, resistance training, and virtual reality-based activities appear to be safe for individuals with leukemia [98] [99] [100] [101] . Exercise may be limited by complications of the cancer and its treatment, such as infection, thromboembolic disease, and hemorrhage [102] . Aerobic and strengthtraining exercises can be safely performed by persons with a stem cell transplant; however, exercises should be less intense, progress slowly, and avoid overtraining [103] .
Modalities and Manual Therapy
Physical modalities such as heat [104] , cryotherapy [105] , electrotherapeutic modalities [106] [107] [108] , laser [109, 110] , and manual therapy [104, 111] are used as adjuncts to reduce pain and facilitate tissue healing and to minimize pain during rehabilitation interventions [105, 112] . Modalities and physical agents require astute understanding of the impact on cancer and the risk of promoting metastatic disease [113, 114] . Numerous indications exist for the use of modalities in pain management but should be applied with caution [104] . Table 5 summarizes contraindications to modalities in cancer survivors.
Oncologic Emergencies
During the course of cancer treatment, there may be signs of emergent conditions and the need for care to manage the sudden onset of serious adverse events. These oncologic emergencies should be recognized by rehabilitation providers to promote acute medical management so as to limit the impact on outcomes.
Morris et al categorized oncologic emergencies according to the mechanism of injury and organ system involved, and outlined 3 categories of oncologic emergencies: (1) structural/mechanically induced, (2) metabolic, and (3) hematological [17] . Table 6 outlines the common presenting symptoms of the conditions associated with these categories of emergencies and their implications for rehabilitation providers.
Conclusion
Rehabilitation is generally safe in oncology patients; however, there are numerous important considerations that are unique to this population. Moreover, oncologydirected therapies and protocols are constantly advancing, and rehabilitation specialists need to keep up to date to ensure the safety of the patients whom they treat. Rehabilitation provides therapeutic interventions that may mitigate loss of function and disability in cancer survivors; however, the frailty of the patients, co-morbid conditions, advanced cancer, side effects of oncology-directed therapies, and a host of other factors contribute to making this one of the most medically complex populations that rehabilitation professionals treat. Assessing each patient through the lens of providing safe rehabilitation interventions in a medically supervised setting is required.
